Code of Federal Regulations · Subpart
Subpart C — Index Of Legally Marketed Unapproved New Animal Drugs For Minor Species
21 C.F.R. pt. 516, subpt. C
- § 516.111 Scope Of This Subpart
- § 516.115 Definitions
- § 516.117 Submission Of Correspondence Under This Subpart
- § 516.119 Permanent-resident U.s. Agent For Foreign Requestors And Holders
- § 516.121 Meetings
- § 516.123 Informal Conferences Regarding Agency Administrative Actions
- § 516.125 Investigational Use Of Minor Species New Animal Drugs To Support Indexing
- § 516.129 Content And Format Of A Request For Determination Of Eligibility For Indexing
- § 516.131 Refuse To File A Request For Determination Of Eligibility For Indexing
- § 516.133 Denying A Request For Determination Of Eligibility For Indexing
- § 516.135 Granting A Request For Determination Of Eligibility For Indexing
- § 516.137 Notification Of Decision Regarding Eligibility For Indexing
- § 516.141 Qualified Expert Panels
- § 516.143 Written Report
- § 516.145 Content And Format Of A Request For Addition To The Index
- § 516.147 Refuse To File A Request For Addition To The Index
- § 516.149 Denying A Request For Addition To The Index
- § 516.151 Granting A Request For Addition To The Index
- § 516.153 Notification Of Decision Regarding Index Listing
- § 516.155 Labeling Of Indexed Drugs
- § 516.157 Publication Of The Index And Content Of An Index Listing
- § 516.161 Modifications To Indexed Drugs
- § 516.163 Change In Ownership Of An Index File
- § 516.165 Records And Reports
- § 516.167 Removal From The Index
- § 516.171 Confidentiality Of Data And Information In An Index File